CervoMed Developed New Oral Tablet Formulation
The company introduced a stable 50 mg tablet designed to improve the pharmacokinetic profile of neflamapimod.
Live Poll
Can pharmaceutical companies be trusted to prioritize patient safety when modifying drug formulations and dosing limits?